Rehab with vibration therapy for balance in CMT1A
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests whether adding a special vibration device to an intensive rehab program helps improve balance in people with Charcot-Marie-Tooth disease type 1A. If you are between 18 and 65 and have mild to moderate leg weakness, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed genetic diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A).
- You are between 18 and 65 years old.
- You have mild to moderate leg weakness (score of 2 or 3 on a 7-point scale).
- You are covered by a health insurance or social security system.
- You can give informed consent and complete all study procedures.
- You do not have other causes of nerve damage like diabetes or kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
This trial tests a new medicine called EDK060 for people with Charcot-Marie-Tooth disease type 1A (CMT1A). The study will check if the drug is safe and how the body processes it, with the goal of finding better treatments for this condition.
This study tests whether a gentle vibrating device applied to the legs can improve walking and balance in children with cerebral palsy. It may help reduce muscle tightness and make moving easier.
This study watches how much you move around at home using a small wearable sensor if you have CMT1A, a genetic nerve condition that affects walking. Researchers want to understand daily activity patterns to better support patients with this condition.
This study looks at fatigue and how it affects walking and balance in people with Charcot-Marie-Tooth type 1A. By comparing results with healthy volunteers, researchers hope to better understand fatigue and find ways to help.
This study looks at how CMT affects walking, balance, and movement. It compares two groups of people with CMT: those who use an ankle-foot orthosis (AFO) and those who have had surgery to correct a foot deformity. The goal is to understand which approach works better for improving mobility.
Hear when a new Charcot-Marie-Tooth Disease Type 1A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.